Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(13 sites)
France
Hopital Henri Mondor, Créteil Chu Dijon Bourgogne, Dijon Chu de Grenoble, La Tronche Institut Paoli Calmettes, Marseille Chu de Montpellier, Montpellier Hopital Saint-Louis, Paris Centre Henri Becquerel, Rouen Chu Brabois, Vandœuvre-lès-Nancy Age range
18 Years and older
Last updated October 2024